Drug shortage
Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray · Mylan Pharmaceuticals Inc., a Viatris Company
FDA drug shortage · To Be Discontinued · updated Sep 4, 2025
Key facts
| Generic name | Azelastine Hydrochloride; Fluticasone Propionate Nasal Spray |
|---|---|
| Company | Mylan Pharmaceuticals Inc., a Viatris Company |
| Presentation | Azelastine Hydrochloride; Fluticasone Propionate, Nasal Spray, 137 ug; 50 ug (NDC 0378-3458-23) |
| Dosage form | Nasal Spray |
| Status | To Be Discontinued |
| Therapeutic category | Pulmonary/Allergy |
| Package NDCs | 0378-3458-23 |
| First posted | Sep 4, 2025 |
| Last updated | Sep 4, 2025 |
| Discontinued | Sep 4, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: